UPM Pharmaceuticals
Bristol, TN
Program data pending ClinicalTrials.gov matching
57.5
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (3)
○ EMA GMP
○ MHRA GMP
Quick Facts: UPM Pharmaceuticals
- Signal Score
- 57.5/100
- Quality Compliance
- Assessment pending
- Headquarters
- Bristol, TN
- Modalities
- Semi-solids (creams, ointments, gels, pastes), Oral solid dose (tablets, capsules)
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About UPM Pharmaceuticals
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSemi-solids (creams, ointments, gels, pastes), Oral solid dose (tablets, capsules)
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
55.0
Manufacturing site information being gathered
Modalities: Semi-solids (creams, ointments, gels, pastes), Oral solid dose (tablets, capsules)
Capacity assessment: 55.0/100
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press3 articles
Manufacturing site information being gathered
Modalities: Semi-solids (creams, ointments, gels, pastes), Oral solid dose (tablets, capsules)
Capacity assessment: 55.0/100
Recent News 3 articles
Which Of These 6 Outsourcing Models Best Suits Your Program? - Bioprocess Online
UPM Pharmaceuticals Celebrates Commitment to Quality on 100-Year Anniversary of its Bristol Manufacturing Site - PR Newswire
Why HPAPI Outsourcing Is Surging - Contract Pharma
Frequently Asked Questions About UPM Pharmaceuticals
What is UPM Pharmaceuticals's CDMO Signal Score?
UPM Pharmaceuticals has a Signal Score of 58/100, based on quality, operations, financial stability, and capacity data.
Evaluating UPM Pharmaceuticals for a manufacturing program?
Use the free AI matchmaker to compare UPM Pharmaceuticals against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.